PTK787 in Refractory or Relapsed Diffuse Large Cell Lymphoma

This study is currently recruiting participants.
Information provided by Duke University

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Lymphoma, Large-Cell, Diffuse
2		Additional conditions recognized in this trial
			Lymphoma
			Lymphoma, Large B-Cell, Diffuse
3		More general conditions related to this trial
			Immune System Diseases
			Immunoproliferative Disorders
			Lymphatic Diseases
			Lymphoma, B-Cell
			Lymphoma, Non-Hodgkin
			Lymphoproliferative Disorders
			Neoplasms
			Neoplasms by Histologic Type
4		Interventions listed in this trial
			PTK787/ZK 222584
5		Additional drug interventions recognized in this trial
			Vatalanib
6		More general drug interventions related to this trial
			Enzyme Inhibitors
			Molecular Mechanisms of Pharmacological Action
			Pharmacologic Actions
			Protein Kinase Inhibitors
7		Sponsors listed in this trial
			Duke University
			Novartis